244 related articles for article (PubMed ID: 15638076)
1. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
Richwien A; Wurm G
Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
[TBL] [Abstract][Full Text] [Related]
2. [Influence of 2-aryl-3-halogen/3-hydroxy-1,4-naphthoquinones with salicylic and cinnamic acid partial structures on the arachidonic acid cascade].
Richwien A; Wurm G
Pharmazie; 2004 Mar; 59(3):163-9. PubMed ID: 15074584
[TBL] [Abstract][Full Text] [Related]
3. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
4. [2-(3-Halogen-4-hydroxyphenyl)-1,4-napthoquinone derivatives from 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-analogs, potent 5-lipoxygenase inhibitors. 27. 1,4-Naphthoquinones].
Wurm G; Schwandt S
Pharmazie; 1999 Jul; 54(7):487-90. PubMed ID: 10445242
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of maesanin and analogs on arachidonic acid metabolizing enzymes.
Abourashed EA; Muhammad I; Resch M; Bauer R; el-Feraly FS; Hufford CD
Planta Med; 2001 Jun; 67(4):360-1. PubMed ID: 11458456
[TBL] [Abstract][Full Text] [Related]
6. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
Tavolari S; Bonafè M; Marini M; Ferreri C; Bartolini G; Brighenti E; Manara S; Tomasi V; Laufer S; Guarnieri T
Carcinogenesis; 2008 Feb; 29(2):371-80. PubMed ID: 18033773
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
Moreau A; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
[TBL] [Abstract][Full Text] [Related]
8. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
9. [Partially hydrogenated aryl-1,2/1,4-anthraquinone derivatives, 5-lipoxygenase inhibitors with arotinoid structure].
Wurm G; Probst R; Schwandt S
Pharmazie; 2001 Jul; 56(7):527-33. PubMed ID: 11487969
[TBL] [Abstract][Full Text] [Related]
10. [Methylated 2-aryl-1,4-naphtoquinone derivatives with diminished antioxidative activity].
Wurm G; Schwandt S
Pharmazie; 2003 Aug; 58(8):531-8. PubMed ID: 12967027
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
12. 1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.
Boehm JC; Smietana JM; Sorenson ME; Garigipati RS; Gallagher TF; Sheldrake PL; Bradbeer J; Badger AM; Laydon JT; Lee JC; Hillegass LM; Griswold DE; Breton JJ; Chabot-Fletcher MC; Adams JL
J Med Chem; 1996 Sep; 39(20):3929-37. PubMed ID: 8831759
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of conformationally constrained aci-reductone mimics of arachidonic acid.
Hopper AT; Witiak DT; Ziemniak J
J Med Chem; 1998 Feb; 41(4):420-7. PubMed ID: 9484493
[TBL] [Abstract][Full Text] [Related]
14. Enzyme selectivity of new cyclooxygenase-2/5 lipoxygenase inhibitors using molecular modeling approach.
Kothekar V; Sahi S; Mishra J
Indian J Biochem Biophys; 2000 Apr; 37(2):86-96. PubMed ID: 10983419
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of N-difluoromethyl-1,2-dihydropyrid-2-one acetic acid regioisomers: dual inhibitors of cyclooxygenases and 5-lipoxygenase.
Yu G; Praveen Rao PN; Chowdhury MA; Abdellatif KR; Dong Y; Das D; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2010 Apr; 20(7):2168-73. PubMed ID: 20202839
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhibitors of arachidonic acid metabolism on corneal reepithelialization in the rat.
Gupta AG; Hirakata A; Proia AD
Exp Eye Res; 1993 Jun; 56(6):701-8. PubMed ID: 8595812
[TBL] [Abstract][Full Text] [Related]
17. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase.
Albert D; Zündorf I; Dingermann T; Müller WE; Steinhilber D; Werz O
Biochem Pharmacol; 2002 Dec; 64(12):1767-75. PubMed ID: 12445866
[TBL] [Abstract][Full Text] [Related]
18. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
Bracher F; Krauss J; Laufer S
Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
[No Abstract] [Full Text] [Related]
19. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: its polymorphism and relation to hemoglobin binding.
Saeed SA; Ahmad N; Ahmed S
Biochem Biophys Res Commun; 2007 Feb; 353(4):915-20. PubMed ID: 17198677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]